Indivior PLC

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

Indivior PLC Is Being Sued For Securities Law Infractions And The Schall Law Firm Is Seeking Shareholder Engagement

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Indivior PLC (NASDAQ: INDV) between February 22, 2024 and July 8, 2024, both dates inclusive (the “Class Period”), of the important October 1, 2024 lead plaintiff deadline.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Indivior PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – INDV

LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

The Schall Law Firm Wants Investors To Participate In A Securities Fraud Lawsuit Against Indivior PLC

BARDA purchased OPVEE, a nalmefene opioid overdose reversal nasal spray Through BARDA's contract with Indivior, communities will be better equipped to respond to mass poisoning emergencies and address biosecurity threats involving synthetic opioids RICHMOND, Va. , Aug. 26, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced the first order of OPVEE® (nalmefene) nasal spray from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support its ongoing national preparedness efforts and help save lives during potential synthetic opioid overdose emergencies.

Indivior Announces BARDA's First Order of OPVEE® to Combat Opioids and Aid in National Preparedness

NEW YORK CITY, NY / ACCESSWIRE / August 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Indivior securities between February 22, 2024, and July 8, 2024, inclusive (the "Class Period").

INDV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Indivior PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

A Case Against Indivior PLC Is Being Pursued For Securities Law Infractions And The Schall Law Firm Is Seeking Shareholder Involvement

NEW YORK, NY / ACCESSWIRE / August 25, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=97910&wire=1 or contact Joseph E. Levi, Esq.

Indivior PLC Class Action: Levi & Korsinsky Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024 – INDV

NEW YORK, NY / ACCESSWIRE / August 24, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=97880&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior Lawsuit -INDV

LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

A Securities Fraud Case Against Indivior PLC Has Been Filed And The Schall Law Firm Wants Investors With Losses To Join

SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Indivior PLC (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024. Indivior is a global pharmaceutical company that develops, manufactures, and markets drugs to treat opioid use disorders (“OUD”) and serious mental illnesses.

Pending Lead Plaintiff Deadline in the INDV Class Action: Robbins LLP Reminds Stockholders with Large Losses of Indivior PLC to Seek Counsel

LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

Indivior PLC Is Being Sued By The Schall Law Firm For Possible Securities Law Violations And Stakeholders Are Encouraged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

Investors With Losses In Indivior PLC Are Urged To Join The Schall Law Firm In A Securities Fraud Lawsuit

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=97451&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Indivior PLC (INDV) Shareholders

NEW YORK , Aug. 22, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Indivior PLC (NASDAQ: INDV). Shareholders who purchased shares of INDV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Investors in Indivior PLC Should Contact The Gross Law Firm Before October 1, 2024 to Discuss Your Rights - INDV

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Indivior PLC (NASDAQ: INDV).

The Gross Law Firm Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming Deadline – INDV

LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

Indivior PLC Shareholders Are Invited To Reach Out To The Schall Law Firm Before October 1, 2024 About A Securities Fraud Suit

NEW YORK, NY / ACCESSWIRE / August 21, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=97113&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that lost money on Indivior PLC (INDV) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

Investors In Indivior PLC Urged To Contact The Schall Law Firm Before October 1, 2024 About Securities Fraud Lawsuit

NEW YORK CITY, NY / ACCESSWIRE / August 20, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Indivior securities between February 22, 2024, and July 8, 2024, inclusive (the "Class Period").

INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Indivior PLC Shareholders Have Opportunity to Lead Class Action Lawsuit

LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ: INDV ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

Stockholders In Indivior PLC Encouraged To Be A Part Of Securities Fraud Lawsuit With The Schall Law Firm

NEW YORK , Aug. 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Indivior PLC (NASDAQ: INDV). Shareholders who purchased shares of INDV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

The Gross Law Firm Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming Deadline - INDV

SAN DIEGO, Aug. 18, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Indivior PLC (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024. Indivior is a global pharmaceutical company that develops, manufactures, and markets drugs to treat opioid use disorders (“OUD”) and serious mental illnesses.

Shareholder Rights Law Firm Robbins LLP Urges INDV Stockholders to Contact the Firm for Information About the Indivior PLC Class Action

LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Indivior PLC ("Indivior" or "the Company") (NASDAQ: INDV ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 22, 2024 and July 8, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 1, 2024.

Indivior PLC Investors Invited To Join Securities Fraud Case With The Schall Law Firm

NEW YORK, Aug. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Indivior PLC (NASDAQ: INDV) between February 22, 2024 and July 8, 2024, both dates inclusive (the “Class Period”), of the important October 1, 2024 lead plaintiff deadline.

ROSEN, A LONGSTANDING LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action – INDV

NEW YORK CITY, NY / ACCESSWIRE / August 18, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Indivior securities between February 22, 2024, and July 8, 2024, inclusive (the "Class Period").

INDV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Indivior PLC Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

News for Indivior PLC Stock (INDV)